Scaramucce in Canada. Macleans.ca versus Gardasil (22)


Il Mecleans è uno dei principali settimanali del Canada.

E’ entrato in contrasto con il Governo canadese e la Merck a causa di alcuni articoli in cui si ipotizza che ci sia stata un pò di fretta nell’immettere la vaccinazione a base di Gardasil nel paese. Gli editori del settimanale sostengono la giornalista Chaty Gulli autrice degli articoli.

http://www.macleans.ca/canada/features/article.jsp?content=20070817_234041_7640

Vi propongo la serie di articoli che riguardano il Gardasil nei quali, fondamentalmente, il settimanale arriva al punto in cui siamo noi (sempre che abbiate avuto il fegato di leggervi tutti e 21 i post precedenti ….. sto pensando ad un post di sintesi, ma, credetemi, la sintesi è difficilissima in questa vicenda complessa)

Si mette in risalto che non si è contro il farmaco ma si chiedono maggiori certezze, si denuncia la mancanza di studi approfonditi degli effetti a lungo termine, si ricordano le migliaia di reazioni avverse, il preoccupante aumento di casi di sindrome di guillain-barre, e

si inizia dal ricordare che le ragazze canadesi non sono cavie:

 

Our girls are not guinea pigs

 

Is an upcoming mass inoculation of a generation unnecessary and potentially dangerous?

http://www.macleans.ca/science/health/article.jsp?content=20070827_108312_108312

CATHY GULLI | August 27, 2007 |

Al settimanale replica il Dr. David Butler-Jones, MD MHSc CCFP FRCPC FACPM
Chief Public Health Officer of Canada

con una lettera in cui fondamentalmente dà dell’irresponsabili agli editori e spiega che la comunità scientifica canadese e internazionale avalla l’utilizzo del vaccino e la sua sicurezza. http://www.macleans.ca/canada/features/article.jsp?content=20070820_175111_300 il Macleans.ca titola così la lettera del ministro della salute canadese:

It is impossible to eliminate all doubt’

 

The Chief Public Health Officer’s full letter to Maclean’s

Macleans.ca staff | Aug 20, 2007 | 5:52 pm EST

Immediata la controreplica della giornalista, con introduzione degli editori che invitano al dibattito:

‘Questions about the vaccine’s safety and effectiveness remain unanswered’

The reporter discusses our controversial cover story

Cathy Gulli | Aug 20, 2007 | 6:06 pm EST
In this week’s issue of Maclean’s, reporter Cathy Gulli looks at the many unanswered questions concerning Gardasil, the controversial HPV vaccine. Canada’s Chief Public Health Officer has written to us to explain why his agency is going forward with the vaccine and his letter is reprinted here. Below, Gulli explains the reasons behind our story.

The health of girls and women, not only in Canada but elsewhere in the world where HPV vaccines such as Gardasil have been approved and administered, is an important issue and warrants thorough public discourse. Until now, the medical benefits, limits, potential dangers, or necessity of such a vaccine have been scarcely debated.

Maclean’s does not support or reject the HPV vaccine. The intention of our article is to present the concerns of medical professionals including epidemiologists, doctors, health care consultants and immunization experts, and to encourage open discussion. They identify a number of issues to consider.”

“Gardasil has been linked to serious negative reactions, which have been documented in a database sponsored by the Food and Drug Administration and the Centres for Disease Control and Prevention in the United States. The Canadian Women’s Health Network is troubled that clinical trials involved fewer than 1,200 girls aged nine to 15. The vaccine’s effectiveness beyond five years is unknown, acknowledge epidemiologists at universities in Canada and the U.S. It does not protect against several HPV strains that can cause cervical cancer, among other illnesses. And the mass inoculation of pre-adolescent and teenage girls doesn’t help women at risk for cervical cancer because they don’t receive Pap tests regularly, warns a doctor and an HPV researcher.

The seriousness and prevalence of HPV should not be diminished. The rush, however, by federal and provincial governments to throw hundreds of millions of dollars into immunization programs is not the only way of dealing with the virus — especially when questions about the vaccine’s safety and effectiveness remain unanswered.” http://www.macleans.ca/canada/features/article.jsp?content=20070820_180138_2832

Nel sito canadese della Merck trovate anche la replica del colosso:

http://www.merckfrosst.ca/assets/en/pdf/press/product_info/gardasil/press_releases/Macleans_QA_GARDASIL_20070817_en.pdf

Ovviamente in Canada qualcuno si è preso anche la briga di andare a dare un’occhiata agli inciuci della Merck.

http://www.thestar.com/News/article/246824

Lobbyists boosted vaccine program

We are talking about a huge amount of disease that can be prevented Sheila Murphy , Merck

Ex-government advisers worked on drug firm’s campaign to push immunization program

Aug 16, 2007 04:30 AM


Health Reporter

Annunci

2 commenti »

  1. […] Nile Virus Scaramucce in Canada. Macleans.ca versus Gardasil (22) » This Summary is from an article posted at alle sette on Tuesday, August 21, 2007 Scaramucce in […]

    Mi piace

  2. […] Scaramucce in Canada. Macleans.ca versus Gardasil (22) […]

    Mi piace

RSS feed for comments on this post · TrackBack URI

Rispondi

Inserisci i tuoi dati qui sotto o clicca su un'icona per effettuare l'accesso:

Logo WordPress.com

Stai commentando usando il tuo account WordPress.com. Chiudi sessione / Modifica )

Foto Twitter

Stai commentando usando il tuo account Twitter. Chiudi sessione / Modifica )

Foto di Facebook

Stai commentando usando il tuo account Facebook. Chiudi sessione / Modifica )

Google+ photo

Stai commentando usando il tuo account Google+. Chiudi sessione / Modifica )

Connessione a %s...

%d blogger hanno fatto clic su Mi Piace per questo: